Twist Bioscience Corp vs Warner Music Group Corp — how do they compare? Twist Bioscience Corp trades at $166.14 (market cap $10.08B), while Warner Music Group Corp trades at $29.36 (market cap $15.12B). The key difference: Warner Music Group Corp is the larger of the two by market cap, and Warner Music Group Corp pays a 2.77% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold Twist Bioscience Corp for 27 Days and Warner Music Group Corp for 96 Days on average.
| TWST | WMG | |
|---|---|---|
Market Cap | $10.08B | $15.12B |
Volume | 4,229,037 | 2,966,414 |
Sector | Health | Media |
52-Week High | $205.00 | $34.72 |
52-Week Low | $25.45 | $23.65 |
Typical Hold Time | 27 Days | 96 Days |
Enterprise Value | $10.01B | $19.42B |
Dividend Yield | — | 2.77% |
Signals from Pluang's Aura AI — not financial advice
TWST trades at $155.65, down 6.78% over 24 hours, with a bearish technical signal and negative cash flows. Revenue growth is strong, reaching $377M in 2025, but the company remains unprofitable with a net income margin of -31.66%. Recent news highlights its role in Eli Lilly's AI-driven drug discovery platform, boosting sentiment despite earnings misses.
The outlook is mixed: analyst consensus is bullish with a $145.20 price target, but high valuation multiples and persistent losses pose risks. Investment opportunity hinges on AI partnerships driving future profitability, while execution risks and cash burn require careful monitoring.
Warner Music Group (WMG) trades at $28.16, up 1.99% today, with a bullish technical signal and strong analyst support. Recent earnings show revenue growth to $6.71B in 2025, though net income margin dipped to 5.44%. The company is actively engaging in AI partnerships and licensing renewals, positioning for future growth in the evolving media landscape.
The outlook for WMG is positive, driven by streaming growth and strategic AI initiatives, with a consensus price target of $39.50 implying significant upside. Risks include margin pressure and competitive dynamics in the music industry, but institutional buying and a 'Moderate Buy' consensus suggest confidence in its long-term value.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →Warner Music Group is the third largest of the three major global record labels, with Vivendi's Universal Music in first and Sony Music in second. Warner's larger segment, recorded music, consists of iconic labels like Atlantic Records, Warner Records, and Parlophone Records and popular artists such as Ed Sheeran, Cardi B, Dua Lipa, and Blake Shelton. Warner Chappell, the firm's publishing arm, is the home to over 65,000 composers and songwriters with over a million copyrights represented. Warner is controlled by Access Industries, which owns an 84% economic interest and 99% of voting rights.
Read more on WMG →